IL214809A0 - Biomarkers for the prediction of renal injury - Google Patents
Biomarkers for the prediction of renal injuryInfo
- Publication number
- IL214809A0 IL214809A0 IL214809A IL21480911A IL214809A0 IL 214809 A0 IL214809 A0 IL 214809A0 IL 214809 A IL214809 A IL 214809A IL 21480911 A IL21480911 A IL 21480911A IL 214809 A0 IL214809 A0 IL 214809A0
- Authority
- IL
- Israel
- Prior art keywords
- biomarkers
- prediction
- renal injury
- renal
- injury
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL214809A IL214809A0 (en) | 2009-03-01 | 2011-08-23 | Biomarkers for the prediction of renal injury |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IL2009/000235 WO2010100633A1 (en) | 2009-03-01 | 2009-03-01 | Biomarkers for the prediction of renal injury |
IL214809A IL214809A0 (en) | 2009-03-01 | 2011-08-23 | Biomarkers for the prediction of renal injury |
Publications (1)
Publication Number | Publication Date |
---|---|
IL214809A0 true IL214809A0 (en) | 2011-11-30 |
Family
ID=41278600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL214809A IL214809A0 (en) | 2009-03-01 | 2011-08-23 | Biomarkers for the prediction of renal injury |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2403958A1 (en) |
IL (1) | IL214809A0 (en) |
WO (1) | WO2010100633A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102539745B (en) * | 2010-12-31 | 2013-03-06 | 中国人民解放军第三〇九医院 | Early diagnosis and early warning kit for transplanted kidney rejection reaction and detection method |
CN103592444A (en) * | 2013-11-27 | 2014-02-19 | 中国人民解放军沈阳军区总医院 | Method for detecting cyclin G1 protein expression in breast cancer and carrying out prognosis evaluation |
JP6232689B2 (en) | 2015-06-25 | 2017-11-22 | 株式会社国際電気通信基礎技術研究所 | Prediction device and prediction program based on multi-organ linkage system |
CN114778845A (en) | 2016-03-29 | 2022-07-22 | 无限生物制药公司 | Pharmaceutical or food composition and method for evaluating in vivo effect of active ingredient |
EP3438282A4 (en) * | 2016-03-29 | 2020-05-06 | Advanced Telecommunications Research Institute International | Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7588892B2 (en) * | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
WO2009083950A2 (en) * | 2007-12-27 | 2009-07-09 | Compugen Ltd. | Biomarkers for the prediction of renal injury |
-
2009
- 2009-03-01 WO PCT/IL2009/000235 patent/WO2010100633A1/en active Application Filing
- 2009-03-01 EP EP09787432A patent/EP2403958A1/en not_active Withdrawn
-
2011
- 2011-08-23 IL IL214809A patent/IL214809A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010100633A1 (en) | 2010-09-10 |
EP2403958A1 (en) | 2012-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2619577A4 (en) | Biomarkers of renal injury | |
IL206631A0 (en) | Biomarkers for the prediction of renal injury | |
HUE064692T2 (en) | Inter prediction | |
PT2559240T (en) | Inter-plane prediction | |
IL222232A0 (en) | Circulating biomarkers for disease | |
IL216720A (en) | Biomarkers for assessing kidney diseases | |
IL215753A0 (en) | Merging search results | |
EP2606353A4 (en) | Circulating biomarkers for disease | |
HK1153538A1 (en) | Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1 | |
GB2474618B (en) | Predictive biomarkers | |
ZA201703026B (en) | Biomarkers for the prediction of incident cancer | |
GB201008340D0 (en) | Biomarkers | |
GB201018056D0 (en) | Biomarkers | |
GB0921329D0 (en) | Biomarker | |
GB0903417D0 (en) | Biomarkers | |
IL214809A0 (en) | Biomarkers for the prediction of renal injury | |
GB201005561D0 (en) | Biomarkers | |
GB201001444D0 (en) | Biomarkers | |
GB0915736D0 (en) | Biomarkers | |
EP2554994A4 (en) | Biomarkers | |
GB201005456D0 (en) | Biomarkers | |
IL217333A0 (en) | Biomarker | |
GB201010316D0 (en) | Biomarkers | |
GB0903391D0 (en) | Biomarkers | |
GB0912175D0 (en) | Biomarker |